Status:
COMPLETED
A Clinical Study to Assess the Efficacy and Safety of SED80 for Use in Cataract Surgery
Lead Sponsor:
iDrop, Inc.
Conditions:
Cataract in Inflammatory Ocular Disorders
Eligibility:
All Genders
40+ years
Phase:
PHASE2
Brief Summary
Patients at least 40 years of age who are undergoing cataract surgery will be randomized to receive treatment with one of four groups of dexamethasone ophthalmic suspension or placebo eye drops to det...
Detailed Description
"Patients undergoing traditional cataract surgery routinely develop inflammation and pain. This study will evaluate 4 arms of either dexamethasone or placebo.
Eligibility Criteria
Inclusion
- Patients undergoing traditional cataract surgery.
Exclusion
- Patients with unusual ocular conditions.
Key Trial Info
Start Date :
September 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 15 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04711213
Start Date
September 14 2020
End Date
November 15 2020
Last Update
January 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre De. Oftalmologia
San Salvador, El Salvador